| 000 | 01139 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517042834.0 | ||
| 264 | 0 | _c20160322 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1534-312X | ||
| 024 | 7 |
_a10.1007/s11894-015-0453-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Toole, Aoibhlinn | |
| 245 | 0 | 0 |
_aOptimizing Biologic Agents in Ulcerative Colitis and Crohn's Disease. _h[electronic resource] |
| 260 |
_bCurrent gastroenterology reports _cAug 2015 |
||
| 300 |
_a32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdalimumab _xtherapeutic use |
| 650 | 0 | 4 |
_aBiological Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aDrug Substitution |
| 650 | 0 | 4 |
_aEvidence-Based Medicine _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfliximab _xtherapeutic use |
| 700 | 1 | _aMoss, Alan C | |
| 773 | 0 |
_tCurrent gastroenterology reports _gvol. 17 _gno. 8 _gp. 32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11894-015-0453-1 _zAvailable from publisher's website |
| 999 |
_c25087889 _d25087889 |
||